Geron: Peers

The FY2024 (Dec) proxy of Geron names 21 peer companies for pay. Pay versus performance data of Geron for that year is not on file, so it has no rank.

Pay peer group, FY2024 (Dec) proxy

1. ADMA Biologics, Inc.Not disclosedNot disclosed
10. ImmunoGen, Inc.Not disclosedNot disclosed
11. Krystal Biotech, Inc.Not disclosedNot disclosed
12. MannKind CorporationNot disclosedNot disclosed
13. Mirum Pharmaceuticals, Inc.Not disclosedNot disclosed
14. Revance Therapeutics, Inc.Not disclosedNot disclosed
15. Rhythm Pharmaceuticals, Inc.Not disclosedNot disclosed
16. Seres Therapeutics, Inc.Not disclosedNot disclosed
17. SpringWorks Therapeutics, Inc.Not disclosedNot disclosed
18. TG Therapeutics, Inc.Not disclosedNot disclosed
19. Travere Therapeutics, Inc.Not disclosedNot disclosed
2. Amylyx Pharmaceuticals, Inc.Not disclosedNot disclosed
20. Veracyte, Inc.Not disclosedNot disclosed
21. Vericel Corp.Not disclosedNot disclosed
3. Ardelyx, Inc.Not disclosedNot disclosed
4. Catalyst Pharmaceuticals, Inc.Not disclosedNot disclosed
5. Coherus Biosciences, Inc.Not disclosedNot disclosed
6. Cytokinetics, Inc.Not disclosedNot disclosed
7. Day One Biopharmaceuticals, Inc.Not disclosedNot disclosed
8. Deciphera Pharmaceuticals, Inc.Not disclosedNot disclosed
9. ImmunityBio, Inc.Not disclosedNot disclosed
21 companies

Changes by year

FY2025 (Dec) proxy

  • AddedAxsome Therapeuticspay peer groupfollowing changes from our prior year peer group: (i) the removal of two companies that were acquired (Deciphera Pharmaceuticals, Inc. and ImmunoGen, Inc.)
  • AddedBlueprint Medicinespay peer groupfollowing changes from our prior year peer group: (i) the removal of two companies that were acquired (Deciphera Pharmaceuticals, Inc. and ImmunoGen, Inc.)
  • AddedDynavax Technologiespay peer groupfollowing changes from our prior year peer group: (i) the removal of two companies that were acquired (Deciphera Pharmaceuticals, Inc. and ImmunoGen, Inc.)
  • AddedIovance Biotherapeuticspay peer groupfollowing changes from our prior year peer group: (i) the removal of two companies that were acquired (Deciphera Pharmaceuticals, Inc. and ImmunoGen, Inc.)
  • AddedLigand Pharmaceuticalspay peer groupfollowing changes from our prior year peer group: (i) the removal of two companies that were acquired (Deciphera Pharmaceuticals, Inc. and ImmunoGen, Inc.)
  • AddedMadrigal Pharmaceuticalspay peer groupfollowing changes from our prior year peer group: (i) the removal of two companies that were acquired (Deciphera Pharmaceuticals, Inc. and ImmunoGen, Inc.)
  • AddedSyndax Pharmaceuticalspay peer groupfollowing changes from our prior year peer group: (i) the removal of two companies that were acquired (Deciphera Pharmaceuticals, Inc. and ImmunoGen, Inc.)
  • RemovedAmylyx Pharmaceuticalspay peer groupfollowing changes from our prior year peer group: (i) the removal of two companies that were acquired (Deciphera Pharmaceuticals, Inc. and ImmunoGen, Inc.)
  • RemovedCoherus Oncology, Inc.pay peer groupfollowing changes from our prior year peer group: (i) the removal of two companies that were acquired (Deciphera Pharmaceuticals, Inc. and ImmunoGen, Inc.)
  • RemovedDeciphera Pharmaceuticals, Inc.pay peer groupfollowing changes from our prior year peer group: (i) the removal of two companies that were acquired (Deciphera Pharmaceuticals, Inc. and ImmunoGen, Inc.)
  • RemovedImmunoGen, Inc.pay peer groupfollowing changes from our prior year peer group: (i) the removal of two companies that were acquired (Deciphera Pharmaceuticals, Inc. and ImmunoGen, Inc.)
  • RemovedRevance Therapeutics, Inc.pay peer groupfollowing changes from our prior year peer group: (i) the removal of two companies that were acquired (Deciphera Pharmaceuticals, Inc. and ImmunoGen, Inc.)
  • RemovedSeres Therapeutics, Inc.pay peer groupfollowing changes from our prior year peer group: (i) the removal of two companies that were acquired (Deciphera Pharmaceuticals, Inc. and ImmunoGen, Inc.)
  • RemovedTravere Therapeuticspay peer groupfollowing changes from our prior year peer group: (i) the removal of two companies that were acquired (Deciphera Pharmaceuticals, Inc. and ImmunoGen, Inc.)

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.